Cargando…

Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation

Elevated pro-inflammatory cytokines exist in both blood and brain of people with schizophrenia but how this affects molecular indices of the blood–brain barrier (BBB) is unclear. Eight mRNAs relating to BBB function, a microglia and three immune cell markers were measured by qPCR in the prefrontal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Helen Q., Catts, Vibeke S., Webster, Maree J., Galletly, Cherrie, Liu, Dennis, O’Donnell, Maryanne, Weickert, Thomas W, Weickert, Cynthia Shannon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156343/ https://www.ncbi.nlm.nih.gov/pubmed/30214039 http://dx.doi.org/10.1038/s41380-018-0235-x

Ejemplares similares

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
por: Boerrigter, Danny, et al.
Publicado: (2017)

O1.5. ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA
por: Weickert, Thomas, et al.
Publicado: (2018)

Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study
por: Joshi, Dipesh, et al.
Publicado: (2015)

Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
por: Murphy, Caitlin E., et al.
Publicado: (2022)

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2019)

Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
por: Catts, Vibeke Sørensen, et al.
Publicado: (2012)

Brain antibodies in the cortex and blood of people with schizophrenia and controls
por: Glass, L J, et al.
Publicado: (2017)

C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
por: Jacomb, Isabella, et al.
Publicado: (2018)

M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS
por: Weickert, Thomas, et al.
Publicado: (2020)

Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia
por: Catts, Vibeke Sørensen, et al.
Publicado: (2015)

23.4 MAPPING MAJOR MOLECULAR CHANGES IN THE DEVELOPMENT OF THE HUMAN CORTEX
por: Webster, Maree, et al.
Publicado: (2018)

Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder
por: Sinclair, Duncan, et al.
Publicado: (2012)

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
por: Fillman, S G, et al.
Publicado: (2016)

Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia
por: Harris, Laura W, et al.
Publicado: (2009)

Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia
por: Vercammen, Ans, et al.
Publicado: (2013)

M174. REDUCED CHEMOKINE SIGNALLING CAPACITY IS ASSOCIATED WITH INHIBITORY INTERNEURON DYSFUNCTION IN SUBCORTICAL BRAIN REGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER
por: Weissleder, Christin, et al.
Publicado: (2020)

Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex
por: Long, Leonora E, et al.
Publicado: (2012)

Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2015)

A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
por: North, Hayley F., et al.
Publicado: (2021)

Distinct Phenotypes of Inflammation Associated Macrophages and Microglia in the Prefrontal Cortex Schizophrenia Compared to Controls
por: Zhu, Yunting, et al.
Publicado: (2022)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness
por: Sinclair, Duncan, et al.
Publicado: (2013)

Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
por: Lambe, Evelyn K., et al.
Publicado: (2011)

Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants
por: Sinclair, Duncan, et al.
Publicado: (2012)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

15. ON THE ROAD TO CURING SCHIZOPHRENIA
por: Weickert, Cynthia Shannon
Publicado: (2018)

Rethinking schizophrenia in the context of normal neurodevelopment
por: Catts, Vibeke S., et al.
Publicado: (2013)

Frontal and Parietal Contributions to Probabilistic Association Learning
por: Rushby, Jacqueline A., et al.
Publicado: (2011)

Developmental Patterns of Doublecortin Expression and White Matter Neuron Density in the Postnatal Primate Prefrontal Cortex and Schizophrenia
por: Fung, Samantha J., et al.
Publicado: (2011)

Speaker 1: Vibeke Catts, Australia
por: Catts, Vibeke S., et al.
Publicado: (2016)

Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation
por: Zhang, Y, et al.
Publicado: (2016)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

O11.5. INCREASED INFLAMMATION AND MACROPHAGE INFILTRATION IS ASSOCIATED WITH ALTERED SUBEPENDYMAL ZONE NEUROGENESIS IN SCHIZOPHRENIA BUT NOT BIPOLAR DISORDER
por: North, Hayley, et al.
Publicado: (2020)

Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
por: Weickert, Thomas W., et al.
Publicado: (2016)

Increases in [(3)H]Muscimol and [(3)H]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to α4 and γ2S mRNA Levels Respectively
por: Verdurand, Mathieu, et al.
Publicado: (2013)

Biomarkers in Schizophrenia: A Brief Conceptual Consideration
por: Weickert, Cynthia S., et al.
Publicado: (2013)

Developmental changes in human dopamine neurotransmission: cortical receptors and terminators
por: Rothmond, Debora A, et al.
Publicado: (2012)

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2018)

Cell proliferation is reduced in the hippocampus in schizophrenia
por: Allen, Katherine M, et al.
Publicado: (2015)

White matter neuron biology and neuropathology in schizophrenia
por: Duchatel, Ryan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t727b34g54ljtdir9qfc88sltt